Unlock instant, AI-driven research and patent intelligence for your innovation.

Structure and purification of venin-class thrombase for preventing and curing thrombotic diseases

A technology for thrombotic diseases and thrombin-like enzymes, which is applied in blood diseases, extracellular fluid diseases, enzymes, etc., can solve problems such as difficulty in obtaining high purity, difficulty in production and purification, and shortage of snake venom resources

Inactive Publication Date: 2004-05-26
CHINA PHARM UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the extraction of TLE from snake venom has two major disadvantages: one is the shortage of snake venom resources, and the other is the difficulty of production and purification
The key to realizing the genetic engineering of the drug is that it is difficult to obtain high-purity TLE

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Structure and purification of venin-class thrombase for preventing and curing thrombotic diseases
  • Structure and purification of venin-class thrombase for preventing and curing thrombotic diseases
  • Structure and purification of venin-class thrombase for preventing and curing thrombotic diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Materials and equipment (the same as below):

[0036] The snake venom is collected from the tip of Wuyi Mountain.

[0037] HiPrep16 / 10DEAE, MonoQ5 / 5HR, SOURCEQ, RESOURCERPC are all produced by Amphamacia.

[0038] Chromatography adopts AKTA expdorer rapid protein purification system, produced by Ampharmacia.

[0039] Dissolve 5 grams of snake venom in 50ml of 0.01mol / L, pH7.5 Tris-HCl buffer, centrifuge it at 7000rpm for 15 minutes after fully dissolving, take the supernatant at 0.01mol / L, pH7.5 Dilute the dialyzed solution by 5 times and filter it with a 0.22 μm microporous membrane. The filtrate was purified by DEAE column chromatography, and the chromatographic conditions were: mobile phase A was 0.01-0.02mol / L, Tris-HCl buffer solution with pH 7.5, B was A solution containing 1mol / L NaCl, and the flow rate was 3ml / min. Using binary gradient elution, The components purified by DEAE column chromatography were purified by MonoQ column, and the chromatographic co...

Embodiment 2

[0041] Dissolve 5 grams of snake venom in 50ml of 0.01mol / L, pH8.2 Tris-HCl buffer, centrifuge it at 7000rpm for 15 minutes after fully dissolving, take the supernatant at 0.01mol / L, pHg.2 Dilute the dialyzed solution by 5 times and filter it with a 0.22 μm microporous membrane. The filtrate was purified by HiPrep16 / 10DEAE column chromatography, and the chromatographic conditions were: mobile phase A was 0.01-0.02mol / L, Tris-HCl buffer solution with pH 8.2, B was A solution containing 1mol / L NaCl, and the flow rate was 3ml / min, using binary gradient elution, The components purified by DEAE column chromatography are purified by SOURCEQ column. The chromatographic conditions are: mobile phase A is 0.01-0.02mol / L, Tris-HCl buffer solution with pH 8.0, B is A solution containing 0.3mol / L NaCl , flow rate: 3ml / min, using binary gradient elution, The components obtained from SOURCEQ column purification were purified by RESOURCE RPC column chromatography. The chromatographic c...

Embodiment 3

[0043] Dissolve 5 grams of snake venom in 0.01mol / L, pH8.5 Tris-HCl buffer solution, centrifuge it at 7000rpm for 15 minutes after fully dissolving, and dialyze the supernatant at 4°C, the dialysate is 0.01mol / L, Tris-HCl buffer solution of pH 8.5, the dialyzed solution was diluted 5 times and then filtered with a 0.22 μm microporous membrane. Take 20ml of the filtrate and purify it by HiPrep16 / 10DEAE column chromatography. The chromatographic conditions are: mobile phase A is 0.01-0.02mol / L, Tris-HCl buffer solution with pH 8.5, B is A solution containing 1mol / L NaCl, and the flow rate is 3ml / min, using binary gradient elution, The components purified by HiPrep16 / 10DEAE column chromatography were purified by SOURCE Q column. The chromatographic conditions were: mobile phase A was 0.01-0.02mol / L, Tris-HCl buffer solution with pH 8.0, B was containing 0.3mol / L NaCl Solution A, flow rate: 3ml / min, using binary gradient elution, The components obtained from SOURCE Q column...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Login to View More

Abstract

The amino acid sequence at N-terminal of a novel thrombase (TLE) extracted from kistric to prevent and treat thrombotic diseases and its purifying method are disclosed. Said thrombase is composed of two same subunits and has molecular weight of 30298Da and pH value of 7-7.5. Its residual amino acid sequence at N-terminal is N-DSPSPWGWYDYDQYQ.

Description

technical field [0001] The present invention relates to a structure and a purification method of thrombin-like enzyme (TLE) derived from the venom of Agkistrodon acutus for preventing and treating thrombotic diseases. The structural characteristics of the extracted TLE and its purification method can be used to treat thrombotic diseases such as cerebral thrombosis, thromboangiitis obliterans, and acute cerebral infarction. Background technique [0002] Ouyang, C et al. first discovered TLE in Agkistrodon venom in 1967, and isolated and purified a TLE in 1971, conducted a comprehensive study on the physical and chemical properties and blood coagulation properties, and determined that the molecular weight of the enzyme is 33500, composed of 17 amino acids (Ougang C, et al, Purification and properties of the anticoagulant principle of Agkistrodon acutus venom, Biochim. et Biophys. Acta 1972, 278; 155-162). Liu Guangfen et al. performed chromatographic separation and activity d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/43A61P7/02A61P7/04C07K1/20C07K14/435C12N9/74
Inventor 吴梧桐孔毅高向东
Owner CHINA PHARM UNIV